In a significant advancement in neuroscience, China has become the first nation to approve an invasive brain-computer interface (BCI) for widespread use. The device, known as NEO, marks a pivotal moment in the realm of brain implants, showcasing the potential to restore motor functions in individuals with severe disabilities. One striking example of its capabilities is illustrated by Dong Hui, a man paralyzed from the neck down after a car accident. Last October, he was able to write his name for the first time in six years, demonstrating the profound impact of this technology on improving quality of life.
The approval of NEO in March signifies not just a medical breakthrough but also positions China as a frontrunner in the global race for brain-computer interface technology. As the nation accelerates its efforts to lead in this innovative field, the implications for both healthcare and technological development are vast. This milestone raises questions about the future of BCIs, including ethical considerations, regulatory frameworks, and the potential for enhancing human capabilities. The global community will be watching closely as China forges ahead in brain implant research and application, possibly paving the way for similar advancements worldwide.
Source: The Download: China’s brain implant ambitions via MIT Technology Review